Low-Dose Danazol for the Treatment of Telomere Related Diseases
Clinical trial NCT03312400 · COMPLETED
Trial details
- NCT number
- NCT03312400
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-08
- Primary completion
- 2025-10-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.